The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-3-(5-ethyl-4-oxo-1,2,3,4,5,6-hexahydrobenzo[b][1,5]diazocin-8-yl)-N-(3-(2-(2-(methylthio)phenyl)pyrrolidin-1-yl)-3-oxopropyl)propanamide ID: ALA4526530
PubChem CID: 155544108
Max Phase: Preclinical
Molecular Formula: C29H38N4O3S
Molecular Weight: 522.72
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN1Cc2cc(CCC(=O)NCCC(=O)N3CCC[C@@H]3c3ccccc3SC)ccc2NCCC1=O
Standard InChI: InChI=1S/C29H38N4O3S/c1-3-32-20-22-19-21(10-12-24(22)30-16-14-28(32)35)11-13-27(34)31-17-15-29(36)33-18-6-8-25(33)23-7-4-5-9-26(23)37-2/h4-5,7,9-10,12,19,25,30H,3,6,8,11,13-18,20H2,1-2H3,(H,31,34)/t25-/m1/s1
Standard InChI Key: LFOHRMGRNIANAA-RUZDIDTESA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
27.8334 -2.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8335 -1.7343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4085 -1.1592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4086 -3.1332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2282 -3.1332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2282 -1.1591 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8074 -1.7343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8043 -2.5529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5106 -2.9632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2205 -2.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2197 -1.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5128 -1.3275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0778 -2.8653 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0946 -3.8877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2842 -3.9929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9279 -2.9651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6359 -2.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3433 -2.9663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0513 -2.5583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3426 -3.7834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7587 -2.9675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4667 -2.5595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1741 -2.9686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8822 -2.5606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.1734 -3.7858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6279 -2.8913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1752 -2.2845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7672 -1.5764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9678 -1.7457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7972 -3.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1884 -4.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3580 -5.0336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1360 -5.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7445 -4.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5717 -3.9382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1773 -3.3895 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.9553 -3.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 5 1 0
5 8 1 0
7 6 1 0
6 3 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
1 13 2 0
4 14 1 0
14 15 1 0
10 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 24 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
26 30 1 6
35 36 1 0
36 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 522.72Molecular Weight (Monoisotopic): 522.2665AlogP: 4.38#Rotatable Bonds: 9Polar Surface Area: 81.75Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 3.93CX LogP: 2.58CX LogD: 2.58Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.48Np Likeness Score: -0.83
References 1. Grädler U, Schwarz D, Blaesse M, Leuthner B, Johnson TL, Bernard F, Jiang X, Marx A, Gilardone M, Lemoine H, Roche D, Jorand-Lebrun C.. (2019) Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies., 29 (23): [PMID:31635932 ] [10.1016/j.bmcl.2019.126717 ] 2. Gaali, Steffen S, Kozany, Christian C, Hoogeland, Bastiaan B, Klein, Marielle M and Hausch, Felix F. 2010-12-09 Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands. [PMID:24900244 ] 3. Shore, Emma R ER and 12 more authors. 2016-03-24 Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis. [PMID:26950392 ] 4. Valasani, Koteswara Rao KR and 8 more authors. 2016-03-10 Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction. [PMID:26985318 ]